CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess
- PMID: 21532842
- PMCID: PMC3076784
CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess
Abstract
Purpose: A high frequency of previously unknown CYP2D6 alleles have been reported in Oceania populations. Genetic and functional properties of these alleles remain unknown.
Methods: We performed analyses of the genetic variability of CYP2D6 and CYP2C19 genes using AmpliChip genotyping in cohorts from two distinct Papua New Guinea (PNG) populations (Kunjingini, n=88; Alexishafen, n=84) focussing on the genetic characterisation of PNG-specific alleles by re-sequencing.
Results: Previously unknown CYP2D6 alleles have population frequencies of 24% (Kunjingini) and 12% (Alexishafen). An allele similar to CYP2D6*1, but carrying the 1661G>C substitution, was the second most frequent CYP2D6 allele (20% Kunjingini and 10% Alexishafen population frequency). Sequencing suggests the CYP2D6* 1661G>C allele originated from a cross-over between CYP2D6*1 and *2 and thus is predicted to confer fully active CYP2D6 enzyme. Two additional predicted full activity alleles [1661G>C;4180G>C] and 31G>A were found in the Kunjingini cohort (frequencies 3 c/c and 1%, respectively) and a novel predicted reduced activity allele [100C>T;1039C>T] was found in the Alexishafen cohort (frequency 2%). A high frequency of ultra-rapid (15%) and notably low frequencies of intermediate and poor CYP2D6 metabolizers (<5%) and a high frequency of poor CYP2C19 metabolizers were observed in PNG. Both CYP2D6 and CYP2C19 showed heterozygote excess that may be explained by exogamy and recent introduction of alleles by migration that are yet to reach HWE in relatively isolated populations.
Conclusion: The CYP2D6*1661 allele common in Oceania may be regarded as functionally equivalent to the full activity CYP2D6*1 allele.
Keywords: CYP2C19; CYP2D6 gene polymorphism; Papua New Guinea; heterozygote excess; novel alleles.
Figures


Similar articles
-
CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721. Pharmacogenomics. 2007. PMID: 18240905
-
Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.Am J Pharmacogenomics. 2004;4(6):395-401. doi: 10.2165/00129785-200404060-00006. Am J Pharmacogenomics. 2004. PMID: 15651900
-
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.Eur J Clin Pharmacol. 2005 Aug;61(7):491-7. doi: 10.1007/s00228-005-0938-1. Epub 2005 Jul 16. Eur J Clin Pharmacol. 2005. PMID: 16025294
-
The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.Mol Diagn Ther. 2006;10(3):135-51. doi: 10.1007/BF03256453. Mol Diagn Ther. 2006. PMID: 16771600 Review.
-
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19817501 Review.
Cited by
-
CYP2C19 and CYP2D6 genotypes in Pacific peoples.Br J Clin Pharmacol. 2016 Nov;82(5):1303-1307. doi: 10.1111/bcp.13045. Epub 2016 Aug 26. Br J Clin Pharmacol. 2016. PMID: 27304207 Free PMC article. Review.
-
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples.Front Genet. 2022 Oct 13;13:1016416. doi: 10.3389/fgene.2022.1016416. eCollection 2022. Front Genet. 2022. PMID: 36313436 Free PMC article.
-
Analysis of CYP2D6 Gene Variant Frequencies in Iranian Population.Iran J Med Sci. 2025 May 1;50(5):351-358. doi: 10.30476/ijms.2024.102645.3570. eCollection 2025 May. Iran J Med Sci. 2025. PMID: 40433186 Free PMC article.
-
Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.Int J Mol Epidemiol Genet. 2012;3(2):115-21. Epub 2012 May 15. Int J Mol Epidemiol Genet. 2012. PMID: 22724048 Free PMC article.
-
Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population.Medicine (Baltimore). 2019 May;98(22):e15891. doi: 10.1097/MD.0000000000015891. Medicine (Baltimore). 2019. PMID: 31145348 Free PMC article.
References
-
- Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005;5:6–13. - PubMed
-
- Eichelbaum M, Ingelman-Sundberg M, Evans WE. Pharmacogenomics and individualized drug therapy. Annu Rev Med. 2006;57:119–137. - PubMed
-
- Weinshilboum R. Inheritance and drug response. N Engl J Med. 2003;348:529–537. - PubMed
-
- Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics. 2007;17:93–101. - PubMed
-
- Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics. 2009;19:170–179. - PubMed
LinkOut - more resources
Full Text Sources